title: Osimertinib Responses After Disease Progression in Patients Who Had Been Receiving Rociletinib.
authors.affiliation: Massachusetts General Hospital Cancer Center, Boston2Harvard Medical School, Boston, Massachusetts.
authors.forename: Lecia V
authors.initials: LV
authors.lastname: Sequist
authors.affiliation: Massachusetts General Hospital Cancer Center, Boston2Harvard Medical School, Boston, Massachusetts.
authors.forename: Zofia
authors.initials: Z
authors.lastname: Piotrowska
authors.affiliation: Massachusetts General Hospital Cancer Center, Boston2Harvard Medical School, Boston, Massachusetts.
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Niederst
authors.affiliation: Massachusetts General Hospital Cancer Center, Boston2Harvard Medical School, Boston, Massachusetts.
authors.forename: Rebecca S
authors.initials: RS
authors.lastname: Heist
authors.affiliation: Harvard Medical School, Boston, Massachusetts3Department of Radiology, Massachusetts General Hospital, Boston.
authors.forename: Subba
authors.initials: S
authors.lastname: Digumarthy
authors.affiliation: Massachusetts General Hospital Cancer Center, Boston2Harvard Medical School, Boston, Massachusetts.
authors.forename: Alice T
authors.initials: AT
authors.lastname: Shaw
authors.affiliation: Massachusetts General Hospital Cancer Center, Boston2Harvard Medical School, Boston, Massachusetts.
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Engelman
mesh_terms: D000178:Acrylamides / Q000627:therapeutic use; D000814:Aniline Compounds; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018450:Disease Progression; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use; D007211:Indoles
chemical_list: D000178:Acrylamides; D000814:Aniline Compounds; D000970:Antineoplastic Agents; D010879:Piperazines; D011743:Pyrimidines; C000596361:osimertinib; D007211:Indoles; C000589977:rociletinib